These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 19672627)
1. Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers. Mita Y; Yasuda Y; Sakai A; Yamamoto H; Toyooka S; Gunduz M; Tanabe S; Naomoto Y; Ouchida M; Shimizu K J Cancer Res Clin Oncol; 2010 Feb; 136(2):249-59. PubMed ID: 19672627 [TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of association between Arg326Gln (rs1503185) and Gln276Pro (rs1566734) polymorphisms of PTPRJ gene and cancer risk. Laczmanska I; Sasiadek MM J Appl Genet; 2019 Feb; 60(1):57-62. PubMed ID: 30661225 [TBL] [Abstract][Full Text] [Related]
4. The PTPN13 Y2081D (T>G) (rs989902) polymorphism is associated with an increased risk of sporadic colorectal cancer. Laczmanska I; Karpinski P; Gil J; Laczmanski L; Makowska I; Bebenek M; Ramsey D; Sasiadek MM Colorectal Dis; 2017 Jul; 19(7):O272-O278. PubMed ID: 28504867 [TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in the PTPN13 gene and risk of squamous cell carcinoma of head and neck. Niu J; Huang YJ; Wang LE; Sturgis EM; Wei Q Carcinogenesis; 2009 Dec; 30(12):2053-8. PubMed ID: 19892796 [TBL] [Abstract][Full Text] [Related]
7. Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer. Lesueur F; Pharoah PD; Laing S; Ahmed S; Jordan C; Smith PL; Luben R; Wareham NJ; Easton DF; Dunning AM; Ponder BA Hum Mol Genet; 2005 Aug; 14(16):2349-56. PubMed ID: 16000320 [TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer susceptibility variants alter risk of breast cancer in a Chinese Han population. Wei W; Jiang M; Luo L; Li Z; Wang P; Dong WQ Genet Mol Res; 2013 Dec; 12(4):6268-74. PubMed ID: 24338422 [TBL] [Abstract][Full Text] [Related]
9. Role of PTPRJ genotype in papillary thyroid carcinoma risk. Iuliano R; Palmieri D; He H; Iervolino A; Borbone E; Pallante P; Cianflone A; Nagy R; Alder H; Calin GA; Trapasso F; Giordano C; Croce CM; de la Chapelle A; Fusco A Endocr Relat Cancer; 2010 Dec; 17(4):1001-6. PubMed ID: 20823296 [TBL] [Abstract][Full Text] [Related]
10. Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancers. Wong KM; Qiu X; Cheng D; Azad AK; Habbous S; Palepu P; Mirshams M; Patel D; Chen Z; Roberts H; Knox J; Marquez S; Wong R; Darling G; Waldron J; Goldstein D; Leighl N; Shepherd FA; Tsao M; Der S; Reisman D; Liu G Cancer Med; 2014 Apr; 3(2):426-33. PubMed ID: 24519853 [TBL] [Abstract][Full Text] [Related]
11. Shared susceptibility loci at 2q33 region for lung and esophageal cancers in high-incidence areas of esophageal cancer in northern China. Zhao XK; Mao YM; Meng H; Song X; Hu SJ; Lv S; Cheng R; Zhang TJ; Han XN; Ren JL; Qi YJ; Wang LD PLoS One; 2017; 12(5):e0177504. PubMed ID: 28542283 [TBL] [Abstract][Full Text] [Related]
12. Loss of Protein Tyrosine Phosphatase Receptor J Expression Predicts an Aggressive Clinical Course in Patients with Esophageal Squamous Cell Carcinoma. Qiao D; Li M; Pu J; Wang W; Zhu W; Liu H Pathol Oncol Res; 2016 Jul; 22(3):541-7. PubMed ID: 26694178 [TBL] [Abstract][Full Text] [Related]
13. TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients. Nairuz T; Rahman M; Bushra MU; Kabir Y Asian Pac J Cancer Prev; 2020 Jul; 21(7):2091-2098. PubMed ID: 32711437 [TBL] [Abstract][Full Text] [Related]
14. Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer. van Puijenbroek M; Dierssen JW; Stanssens P; van Eijk R; Cleton-Jansen AM; van Wezel T; Morreau H J Mol Diagn; 2005 Nov; 7(5):623-30. PubMed ID: 16258161 [TBL] [Abstract][Full Text] [Related]
15. Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms. Guo Y; Zhang X; Tan W; Miao X; Sun T; Zhao D; Lin D Pharmacogenet Genomics; 2007 Mar; 17(3):197-205. PubMed ID: 17460548 [TBL] [Abstract][Full Text] [Related]
16. The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians. Natukula K; Jamil K; Pingali UR; Attili VS; Madireddy UR Asian Pac J Cancer Prev; 2013; 14(9):5275-9. PubMed ID: 24175813 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 -592C/A, but not -1082A/G promoter single nucleotide polymorphism, is associated with a decreased risk of colorectal cancer in an ethnic Kashmiri population: a case-control study. Banday MZ; Sameer AS; Chowdri NA; Haq E Eur J Cancer Prev; 2017 Nov; 26(6):476-490. PubMed ID: 28538040 [TBL] [Abstract][Full Text] [Related]
18. Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis. Trapasso F; Drusco A; Costinean S; Alder H; Aqeilan RI; Iuliano R; Gaudio E; Raso C; Zanesi N; Croce CM; Fusco A DNA Cell Biol; 2006 Jun; 25(6):376-82. PubMed ID: 16792508 [TBL] [Abstract][Full Text] [Related]
19. The nonreceptor-type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non-small cell lung cancer. Scrima M; De Marco C; De Vita F; Fabiani F; Franco R; Pirozzi G; Rocco G; Malanga D; Viglietto G Am J Pathol; 2012 Mar; 180(3):1202-1214. PubMed ID: 22245727 [TBL] [Abstract][Full Text] [Related]
20. High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin's lymphoma. Aya-Bonilla C; Green MR; Camilleri E; Benton M; Keane C; Marlton P; Lea R; Gandhi MK; Griffiths LR Genes Chromosomes Cancer; 2013 May; 52(5):467-79. PubMed ID: 23341091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]